Ardent Health, Inc.

Equities

ARDT

US03980N1072

Market Closed - Nyse Other stock markets 16:00:02 2025-12-05 EST			5-day change	1st Jan Change
8.790 ^USD	-0.90%		+0.11%	-48.54%

11-18	Ardent Health, Inc. authorizes a Buyback Plan.	CI
11-18	Ardent Health, Inc. announces an Equity Buyback for $50 million worth of its shares.	CI

Transcript : Ardent Health, Inc., Q3 2025 Earnings Call, Nov 13, 2025

Published on 11/13/2025 at 10:35 am EST - Modified on 11/13/2025 at 02:05 pm EST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today. At this time, I would like to

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Ardent Health, Inc.

11-18	Ardent Health, Inc. authorizes a Buyback Plan.	CI
11-18	Ardent Health, Inc. announces an Equity Buyback for $50 million worth of its shares.	CI
11-18	Ardent Health Partners Launches $50 Million Buyback Program	MT
11-18	Ardent Health announces $50 million share repurchase program authorization	RE
11-18	KeyBanc Downgrades Ardent Health Partners to Sector Weight From Overweight	MT
11-17	Sector Update: Health Care Stocks Softer Late Afternoon	MT
11-17	Sector Update: Health Care	MT
11-17	Ardent Health Shares Drop After Downgrade From KeyBanc	MT
11-17	UBS Adjusts Price Target on Ardent Health Partners to $14.50 From $17, Maintains Buy Rating	MT
11-17	KeyBanc Downgrades Ardent Health to Sector Weight From Overweight, Removes $20 Price Target	MT
11-14	Ardent Health Partners Shares Fall After Morgan Stanley Downgrade	MT
11-14	Truist Cuts Price Target on Ardent Health to $13 From $21, Keeps Buy Rating	MT
11-14	Morgan Stanley Downgrades Ardent Health to Equalweight From Overweight, Cuts Price Target to $12 From $22	MT
11-14	RBC Cuts Price Target on Ardent Health to $16 From $21, Keeps Outperform Rating	MT
11-13	Top Midday Decliners	MT
11-13	Ardent Health, Inc., Q3 2025 Earnings Call, Nov 13, 2025
11-13	Government Reopening in Focus as US Equity Futures Turn Cautiously Lower Pre-Bell	MT
11-13	Top Premarket Decliners	MT
11-12	Ardent Health Q3 Swings to Loss, Revenue Rises; 2025 EPS Guidance Cut; Shares Fall After Hours	MT
11-12	(ARDT) Ardent Health Expects Full Year 2025 Revenue Range $6.20B - $6.45B, vs. FactSet Est of $6.35B	MT
11-12	(ARDT) Ardent Health Expects Full Year 2025 EPS Range $0.85 - $1.03, vs. FactSet Est of $1.89	MT
11-12	Earnings Flash (ARDT) Ardent Health Posts Q3 Loss $0.17, vs. FactSet Est of $0.42 in Earnings	MT
11-12	Earnings Flash (ARDT) Ardent Health, Inc. Reports Q3 Revenue $1.58B, vs. FactSet Est of $1.55B	MT
11-12	Ardent Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
11-12	Ardent Health, Inc. Revises Earnings Guidance for the Full-Year Ending December 31, 2025	CI